When Ted Hudacko's wife told him their son was transgender, he delved into the research on medical transition. He learned that puberty blockers could impair cognition and bone density -- and he wasn't even sure his son was transgender.
In August 2019, Ted Hudacko’s wife, Christine, walked into his home office with two announcements: she was leaving Ted, and their 15-year-old son, Drew*, was transgender. Ted, a Bay Area father of two and software engineer at Apple, was then preoccupied with a grueling work project. He hadn’t slept well in weeks and says he begged to have this conversation after he had gotten some rest. But Christine walked out, taking the kids to stay with her at a neighbor’s house.
Ted was deeply skeptical that the boy he’d coached in little league was actually a young woman, but he tried to keep an open mind. Nevertheless, Ted was adamant that he did not want Drew to begin medical transition. Ted delved into the research on medical transition and gender dysphoria (severe discomfort in one’s biological sex). He learned that puberty blockers could impair cognition and diminish bone density. If given puberty blockers along with estrogen, Drew could become permanently infertile. Ted wasn’t even sure his son had gender dysphoria.
Continue reading the entire piece here at the New York Post
Abigail Shrier is a writer living in Los Angeles and the author of Irreversible Damage: The Transgender Craze Seducing Our Daughters. Adapted from City Journal.
Photo by stockage/iStock